Cheng, Yu
Yang, Rong
Jia, Yu
Zhou, Yiheng
Yao, Yi
Shen, Can
Li, Dongze
Zeng, Rui
Wan, Zhi
Zhao, Qian
Jiang, Lihua
Liao, Xiaoyang
Funding for this research was provided by:
Sichuan Provincial Science and Technology Support Program (2023YFS0027, 2023YFS0240, 2023YFS0074, 2023NSFSC1652, 2023YFS0027, 2023YFS0240, 2023YFS0074, 2023NSFSC1652, 2023YFS0027, 2023YFS0240, 2023YFS0074, 2023NSFSC1652, 2023YFS0027, 2023YFS0240, 2023YFS0074, 2023NSFSC1652)
Sichuan Provincial Health Commission (2023-101, 2024-102, 2023-101, 2024-102)
Postdoctor Research Fund of West China Hospital, Sichuan University (2024HXBH067, 2024HXBH067)
CDHT Health Bureau (2024004, 2024005, 2024004, 2024005, 2024004, 2024005, 2024004, 2024005)
Article History
Received: 9 December 2024
Accepted: 5 February 2025
First Online: 25 February 2025
Declarations
:
: The authors declare no competing interests.
: of the UK Biobank study was approved by the NHS National Research Ethics Service (16/NW/0274). The experimental protocols were established according to the ethical guidelines of the Helsinki Declaration. Written informed consent was obtained from individual or guardian participants. All methods were carried out in accordance with guidelines and regulations developed by the UK Biobank. Data usage was approved by the Human Ethical Committee of the West China Hospital of Sichuan University (2023 − 1207).